Uterine fibroid treatment device market to grow by USD 2,692.65 million from 2022 to 2027|Increase in healthcare expenditure to influence market growth - Technavio

NEW YORK, Aug. 3, 2023 /PRNewswire/ -- The uterine fibroid treatment device market is expected to grow by USD 2,692.65 million from 2022 to 2027, according to Technavio. As per the latest report, the market will progress at a CAGR of 9.12% during the forecast period. Improving healthcare systems in emerging economies is an emerging uterine fibroid treatment device market trend. Underserved markets for healthcare products and services, including medical devices significantly represented in developing and emerging economies, such as Brazil, Russia, India, China, Saudi Arabia, and Mexico. Furthermore, even though emerging local companies in developing countries are making efforts toward creating innovative products with local materials at affordable prices, there is still a huge potential for established global companies in these developing markets. Hence, such trends boost the growth of the uterine fibroid treatment device market during the forecast period. View a Sample Report within minutes!

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Our uterine fibroid treatment device market report covers the following areas:

• Uterine Fibroid Treatment Device Market size
• Uterine Fibroid Treatment Device Market trends
• Uterine Fibroid Treatment Device Market industry analysis
• Uterine Fibroid Treatment Device Market five forces analysis
• Uterine Fibroid Treatment Device Market competitive landscape

• Therapeutic area
• Invasive treatment
• Minimally invasive treatment
• Non-invasive treatment
• Technology 
• Surgical Techniques
• Laparoscopic Techniques
• Ablation Techniques
• Embolization Techniques
• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

The invasive treatment segment will be significant during the forecast period. This segment includes surgical methods that involve invasive procedures to remove or destroy uterine fibroids and currently hold a significant share of the market. The significant market share is because many women continue to opt for surgical methods as the standard treatment for fibroids. Hysterectomy, myomectomy, and others are some of the major examples of invasive uterine fibroids treatment. Traditional surgical procedures provide an opportunity for physicians to accurately remove the fibroids with minimal risks compared with any other alternative treatments. Hence, such factors boost the invasive treatment segment of the uterine fibroid treatment device market during the forecast period.

To learn more about the global trends impacting the future of market research, download a sample report!

An increase in healthcare expenditure drives the growth of the uterine fibroid treatment device market. In 2021, it was estimated that global healthcare expenditure was expected to grow by 5.8% and reach USD 8.8 trillion. Due to the increase in healthcare expenditure, the demand for medical devices will rise, which will increase the demand for uterine fibroid treatment devices. Furthermore, serving developing countries will require technological innovations as well as innovations in delivery and business models by healthcare companies. Hence, such factors boost the growth of the uterine fibroid treatment device market during the forecast period.

The high cost of treatment of uterine fibroid challenges the growth of the uterine fibroid treatment device market. These devices and procedures can be expensive, and the high cost of treatment can be a significant barrier to the growth of the market. The cost of purchasing, maintaining, and upgrading these devices may also be prohibitive for some healthcare providers. This leads to delays in the adoption of new and innovative devices. Hence, such challenges impede the growth of the uterine fibroid treatment device market during the forecast period.

What's New? -

• Special coverage on the Russia-Ukraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
• Global competitiveness and key competitor positions
• Market presence across multiple geographical footprints - Strong/Active/Niche/Trivial - Buy the report!

The market is concentrated, and the degree of concentration will accelerate during the forecast period. We provide a detailed analysis of around 25 vendors operating in the Uterine Fibroid Treatment Device Market, including some of the vendors such as Boston Scientific Corp., Conmed Corp., Gynesonics Inc., Hologic Inc., INSIGHTEC Ltd., KARL STORZ SE and Co. KG, Lumenis Be Ltd, Medtronic Plc, Merit Medical Systems Inc., Minerva Surgical Inc., Olympus Corp., and The Cooper Companies Inc. Backed with competitive intelligence and benchmarking, our research reports on the Uterine Fibroid Treatment Device Market are designed to provide entry support, customer profile, and M&As as well as go-to-market strategy support.

Company Offerings

• Boston Scientific Corp. - The company offers uterine fibroid treatment devices such as Bead Block devices.
• Conmed Corp. - The company offers uterine fibroid treatment devices such as the AirSeal system.
• Gynesonics Inc. - The company offers uterine fibroid treatment devices such as Sonata System.

Uterine Fibroid Treatment Device Market 2023-2027: Key Highlights

• CAGR of the market during the forecast period 2023-2027
• Detailed information on factors that will assist uterine fibroid treatment device market growth during the next five years
• Estimation of the uterine fibroid treatment device market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the uterine fibroid treatment device market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of uterine fibroid treatment device market vendors

Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

Related Reports:
Based on Technavio's market sizing methodology, the gynecological cancers therapeutics market size is predicted to surge to USD 14.22 billion from 2021 to 2026 at a CAGR of 14.67%. This report further entails gynecological cancers therapeutics market segmentations, including Type - Uterine cancer, Ovarian cancer, cervical cancer, and others, and Geography - North America, Europe, Asia, and Rest of World (ROW). The increasing incidence of gynecological cancers is notably driving the gynecological cancers therapeutics market growth.

The intrauterine contraceptive devices (IUD) market is estimated to grow at a CAGR of 3.98% between 2022 and 2027. The size of the market is forecast to increase by USD 965.49 million. The market has been segmented by Type (Hormonal intrauterine device and Copper intrauterine device), End-user (Hospitals, Gynecology clinics, and Others), and Geography (North America, Europe, APAC, and Rest of World (ROW)). The increasing number of unplanned pregnancies and unwanted abortions is notably driving the IUD market growth.

Table Of Contents :

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Therapeutic Area
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Technology
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027 
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global uterine fibroid treatment device market 2017 - 2021 
• Exhibit 18: Historic Market Size – Data Table on global uterine fibroid treatment device market 2017 - 2021 ($ million)

• 4.2 Therapeutic Area Segment Analysis 2017 - 2021 
• Exhibit 19: Historic Market Size – Therapeutic Area Segment 2017 - 2021 ($ million)

• 4.3 Technology Segment Analysis 2017 - 2021 
• Exhibit 20: Historic Market Size – Technology Segment 2017 - 2021 ($ million)

• 4.4 Geography Segment Analysis 2017 - 2021 
• Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)

• 4.5 Country Segment Analysis 2017 - 2021 
• Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

• 5.2 Bargaining power of buyers 
• Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

• 5.3 Bargaining power of suppliers 
• Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

• 5.4 Threat of new entrants 
• Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

• 5.5 Threat of substitutes 
• Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Therapeutic Area

• 6.1 Market segments
• Exhibit 30: Chart on Therapeutic Area - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Therapeutic Area - Market share 2022-2027 (%)

• 6.2 Comparison by Therapeutic Area 
• Exhibit 32: Chart on Comparison by Therapeutic Area
• Exhibit 33: Data Table on Comparison by Therapeutic Area

• 6.3 Invasive treatment - Market size and forecast 2022-2027 
• Exhibit 34: Chart on Invasive treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Invasive treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Invasive treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Invasive treatment - Year-over-year growth 2022-2027 (%)

• 6.4 Minimally invasive treatment - Market size and forecast 2022-2027 
• Exhibit 38: Chart on Minimally invasive treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Minimally invasive treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Minimally invasive treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Minimally invasive treatment - Year-over-year growth 2022-2027 (%)

• 6.5 Non-invasive treatment - Market size and forecast 2022-2027 
• Exhibit 42: Chart on Non-invasive treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Non-invasive treatment - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Non-invasive treatment - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Non-invasive treatment - Year-over-year growth 2022-2027 (%)

• 6.6 Market opportunity by Therapeutic Area 
• Exhibit 46: Market opportunity by Therapeutic Area ($ million)
• Exhibit 47: Data Table on Market opportunity by Therapeutic Area ($ million)

7 Market Segmentation by Technology

• 7.1 Market segments
• Exhibit 48: Chart on Technology - Market share 2022-2027 (%)
• Exhibit 49: Data Table on Technology - Market share 2022-2027 (%)

• 7.2 Comparison by Technology 
• Exhibit 50: Chart on Comparison by Technology
• Exhibit 51: Data Table on Comparison by Technology

• 7.3 Surgical techniques - Market size and forecast 2022-2027 
• Exhibit 52: Chart on Surgical techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Surgical techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Surgical techniques - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Surgical techniques - Year-over-year growth 2022-2027 (%)

• 7.4 Laparoscopic techniques - Market size and forecast 2022-2027 
• Exhibit 56: Chart on Laparoscopic techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Laparoscopic techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Laparoscopic techniques - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Laparoscopic techniques - Year-over-year growth 2022-2027 (%)

• 7.5 Ablation techniques - Market size and forecast 2022-2027 
• Exhibit 60: Chart on Ablation techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Ablation techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Ablation techniques - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Ablation techniques - Year-over-year growth 2022-2027 (%)

• 7.6 Embolization techniques - Market size and forecast 2022-2027 
• Exhibit 64: Chart on Embolization techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Data Table on Embolization techniques - Market size and forecast 2022-2027 ($ million)
• Exhibit 66: Chart on Embolization techniques - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Embolization techniques - Year-over-year growth 2022-2027 (%)

• 7.7 Market opportunity by Technology 
• Exhibit 68: Market opportunity by Technology ($ million)
• Exhibit 69: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview 
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation 
• Exhibit 71: Chart on Market share by geography 2022-2027 (%)
• Exhibit 72: Data Table on Market share by geography 2022-2027 (%)

• 9.2 Geographic comparison 
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027 
• Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)

• 9.4 Europe - Market size and forecast 2022-2027 
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)

• 9.5 Asia - Market size and forecast 2022-2027 
• Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)

• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027 
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

• 9.7 US - Market size and forecast 2022-2027 
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)

• 9.8 Japan - Market size and forecast 2022-2027 
• Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)

• 9.9 Germany - Market size and forecast 2022-2027 
• Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)

• 9.10 China - Market size and forecast 2022-2027 
• Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)

• 9.11 Canada - Market size and forecast 2022-2027 
• Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)

• 9.12 Market opportunity by geography 
• Exhibit 111: Market opportunity by geography ($ million)
• Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges 
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption

• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered

• 12.2 Market positioning of vendors 
• Exhibit 118: Matrix on vendor position and classification

• 12.3 Boston Scientific Corp. 
• Exhibit 119: Boston Scientific Corp. - Overview
• Exhibit 120: Boston Scientific Corp. - Business segments
• Exhibit 121: Boston Scientific Corp. - Key news
• Exhibit 122: Boston Scientific Corp. - Key offerings
• Exhibit 123: Boston Scientific Corp. - Segment focus

• 12.4 Conmed Corp.
• Exhibit 124: Conmed Corp. - Overview
• Exhibit 125: Conmed Corp. - Business segments
• Exhibit 126: Conmed Corp. - Key offerings
• Exhibit 127: Conmed Corp. - Segment focus

• 12.5 Gynesonics Inc.
• Exhibit 128: Gynesonics Inc. - Overview
• Exhibit 129: Gynesonics Inc. - Product / Service
• Exhibit 130: Gynesonics Inc. - Key offerings

• 12.6 Hologic Inc.
• Exhibit 131: Hologic Inc. - Overview
• Exhibit 132: Hologic Inc. - Business segments
• Exhibit 133: Hologic Inc. - Key news
• Exhibit 134: Hologic Inc. - Key offerings
• Exhibit 135: Hologic Inc. - Segment focus

• 12.7 INSIGHTEC Ltd.
• Exhibit 136: INSIGHTEC Ltd. - Overview
• Exhibit 137: INSIGHTEC Ltd. - Product / Service
• Exhibit 138: INSIGHTEC Ltd. - Key offerings

• 12.8 KARL STORZ SE and Co. KG 
• Exhibit 139: KARL STORZ SE and Co. KG - Overview
• Exhibit 140: KARL STORZ SE and Co. KG - Product / Service
• Exhibit 141: KARL STORZ SE and Co. KG - Key news
• Exhibit 142: KARL STORZ SE and Co. KG - Key offerings

• 12.9 Lumenis Be Ltd
• Exhibit 143: Lumenis Be Ltd - Overview
• Exhibit 144: Lumenis Be Ltd - Product / Service
• Exhibit 145: Lumenis Be Ltd - Key offerings

• 12.10 Medtronic Plc
• Exhibit 146: Medtronic Plc - Overview
• Exhibit 147: Medtronic Plc - Business segments
• Exhibit 148: Medtronic Plc - Key news
• Exhibit 149: Medtronic Plc - Key offerings
• Exhibit 150: Medtronic Plc - Segment focus

• 12.11 Merit Medical Systems Inc. 
• Exhibit 151: Merit Medical Systems Inc. - Overview
• Exhibit 152: Merit Medical Systems Inc. - Business segments
• Exhibit 153: Merit Medical Systems Inc. - Key offerings
• Exhibit 154: Merit Medical Systems Inc. - Segment focus

• 12.12 Minerva Surgical Inc. 
• Exhibit 155: Minerva Surgical Inc. - Overview
• Exhibit 156: Minerva Surgical Inc. - Product / Service
• Exhibit 157: Minerva Surgical Inc. - Key offerings

• 12.13 Olympus Corp.
• Exhibit 158: Olympus Corp. - Overview
• Exhibit 159: Olympus Corp. - Business segments
• Exhibit 160: Olympus Corp. - Key news
• Exhibit 161: Olympus Corp. - Key offerings
• Exhibit 162: Olympus Corp. - Segment focus

• 12.14 The Cooper Companies Inc. 
• Exhibit 163: The Cooper Companies Inc. - Overview
• Exhibit 164: The Cooper Companies Inc. - Business segments
• Exhibit 165: The Cooper Companies Inc. - Key offerings
• Exhibit 166: The Cooper Companies Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist 
• Exhibit 167: Inclusions checklist
• Exhibit 168: Exclusions checklist

• 13.3 Currency conversion rates for US$ 
• Exhibit 169: Currency conversion rates for US$

• 13.4 Research methodology
• Exhibit 170: Research methodology
• Exhibit 171: Validation techniques employed for market sizing
• Exhibit 172: Information sources

• 13.5 List of abbreviations 
• Exhibit 173: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Infiniti Research, Inc.